Skip to main content
logo
GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
6.60
-1.21 (-15.49%)
Sep 17, 2026, 9:55 AM EDT - Market open

GT Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-4.76-28.35-13.16-7.6-20.88-58.01
Loss (Gain) From Sale of Investments
----0.050.030.03
Stock-Based Compensation
0.520.430.232.27.6533.93
Other Operating Activities
-11.6515.93-0.8-5.23-0.020.51
Change in Accounts Payable
0.24-1.30.941.96-2.037.08
Change in Other Net Operating Assets
1.230.38-0.11-0.140.040.86
Operating Cash Flow
-14.43-12.91-12.9-8.85-15.22-15.61
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Investment in Securities
--12.89-2.0112.15-23.04
Investing Cash Flow
--12.89-2.0112.15-23.04

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-----1.21
Total Debt Issued
-----1.21
Net Debt Issued (Repaid)
-----1.21
Issuance of Common Stock
5.025.52.986.27-41.11
Repurchase of Common Stock
-----0.22-
Preferred Dividends Paid
-0.23-0.23----
Dividends Paid
-0.23-0.23----
Financing Cash Flow
14.1615.782.986.27-0.2242.32

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-0.272.862.97-4.59-3.33.67

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-14.43-12.91-12.9-8.85-15.22-15.61
Free Cash Flow Growth
------
Free Cash Flow Per Share
-16.76-58.56-170.02-164.20-358.12-415.70
Levered Free Cash Flow
-8.87-12.01-9.62-4.68-10.91-0.82
Unlevered Free Cash Flow
-8.71-11.93-9.62-4.55-10.9-0.38

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
---0.21--
Change in Working Capital
1.47-0.920.831.83-1.997.94
SEC Filings: 10-K · 10-Q